Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29776 - 29800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	OAS2	4939	upregulated	decitabine results in increased expression of OAS2 mRNA	12q24.13	A21915
Decitabine	Approved Investigational	OGG1	4968	upregulated	decitabine results in increased expression of OGG1 mRNA	3p25.3	A21181
Decitabine	Approved Investigational	OLA1	29789	downregulated	decitabine results in decreased expression of OLA1 mRNA	2q31.1	A21913
Decitabine	Approved Investigational	OPRM1	4988	upregulated	decitabine results in increased expression of OPRM1 mRNA	6q25.2	A21953
Decitabine	Approved Investigational	P4HA2	8974	upregulated	decitabine results in increased expression of P4HA2 mRNA	5q31.1	A20985
Decitabine	Approved Investigational	PABPC3	5042	downregulated	decitabine results in decreased expression of PABPC3 mRNA	13q12.13	A21913
Decitabine	Approved Investigational	PAGE2	203569	upregulated	decitabine results in increased expression of PAGE2 mRNA	Xp11.21	A21915
Decitabine	Approved Investigational	PAGE2B	389860	upregulated	decitabine results in increased expression of PAGE2B mRNA	Xp11.21	A21915
Decitabine	Approved Investigational	PAGE5	90737	upregulated	decitabine results in increased expression of PAGE5 mRNA	Xp11.21	A21915
Decitabine	Approved Investigational	PAX6	5080	upregulated	decitabine results in increased expression of PAX6 mRNA	11p13	A21919
Decitabine	Approved Investigational	PCYT2	5833	upregulated	decitabine results in increased expression of PCYT2 mRNA	17q25.3	A21917
Decitabine	Approved Investigational	PDGFRB	5159	upregulated	decitabine results in increased expression of PDGFRB mRNA	5q32	A21915
Decitabine	Approved Investigational	PDK2	5164	upregulated	decitabine results in increased expression of PDK2 mRNA	17q21.33	A21917
Decitabine	Approved Investigational	PELI1	57162	upregulated	decitabine results in increased expression of PELI1 mRNA	2p14	A21321
Decitabine	Approved Investigational	PEX19	5824	downregulated	decitabine results in decreased expression of PEX19 mRNA	1q23.2	A20985
Decitabine	Approved Investigational	PFKFB3	5209	upregulated	decitabine results in increased expression of PFKFB3 mRNA	10p15.1	A21915
Decitabine	Approved Investigational	PGR	5241	upregulated	decitabine results in increased expression of PGR mRNA	11q22.1	A21918
Decitabine	Approved Investigational	PGR	5241	upregulated	decitabine results in increased expression of PGR mRNA alternative form	11q22.1	A22007
Decitabine	Approved Investigational	PHLDA2	7262	upregulated	decitabine results in increased expression of PHLDA2 mRNA	11p15.4	A21915
Decitabine	Approved Investigational	PHOX2B	8929	upregulated	decitabine results in increased expression of PHOX2B mRNA	4p13	A22008
Decitabine	Approved Investigational	PIK3CD	5293	upregulated	decitabine results in increased expression of PIK3CD mRNA	1p36.22	A21935
Decitabine	Approved Investigational	PIK3CG	5294	upregulated	decitabine results in increased expression of PIK3CG mRNA	7q22.3	A21930
Decitabine	Approved Investigational	PIM1	5292	upregulated	decitabine results in increased expression of PIM1 mRNA	6p21.2	A21321
Decitabine	Approved Investigational	PIP4K2B	8396	downregulated	decitabine results in decreased expression of PIP4K2B mRNA	17q12	A20985
Decitabine	Approved Investigational	PJA1	64219	upregulated	decitabine results in increased expression of PJA1 mRNA	Xq13.1	A20985

Displaying entries 29776 - 29800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability